Packer M. Are the benefits of SGLT2 inhibitors in heart failure and a reduced ejection
fraction influenced by background therapy? Expectations and realities of a new
standard of care. Eur Heart J 2020 Apr 29. pii: 5827051. doi: 10.1093.
PMID: 32350522